Table 3. Multivariable generalized estimating equation population-averaged model of virological suppression up to 24 months of ART (n = 10 458)a.
Variable | Adjusted OR | 95% CI | P-value |
Male gender | 0.89 | 0.80–1.00 | 0.051 |
Age: 16–19 years | 0.44 | 0.27–0.72 | 0.001 |
20–29 yearsb | 1.00 | ||
30–39 years | 1.12 | 0.99–1.26 | 0.069 |
≥40 years | 1.69 | 1.33–2.16 | <0.001 |
WHO stage: I/IIb | 1.00 | ||
III/IV | 0.86 | 0.76–0.97 | 0.018 |
Baseline CD4 cell count (µL) | 1.00 | 0.99–1.00 | 0.149 |
Western Cape provinceb | 1.00 | ||
Eastern Cape province | 0.41 | 0.32–0.52 | <0.001 |
KwaZulu-Natal province | 0.69 | 0.59–0.82 | <0.001 |
Mpumalanga province | 0.30 | 0.17–0.51 | <0.001 |
Primary healthcare facilitiesb | 1.00 | ||
District hospitals | 0.76 | 0.59–0.97 | 0.030 |
Regional hospitals | 0.64 | 0.56–0.75 | <0.001 |
ART duration 6 monthsb | 1.00 | ||
ART duration 12 months | 0.83 | 0.78–0.92 | <0.001 |
ART duration 18–24 months | 0.83 | 0.73–0.95 | 0.007 |
Estimates adjusted for all variables shown and year of starting ART.
Reference category.
WHO-World Health Organisation; CI-confidence interval; ART-antiretroviral therapy.